Financial Statements — XE
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 1.15 | 0.22 |
| Short-term Investments | 0.49 | 0.45 |
| Accounts Receivable | 0.04 | 0.02 |
| Total Current Assets | 1.79 | 0.77 |
| Property, Plant & Equipment | 0.12 | 0.07 |
| Total Non-current Assets* | 0.46 | 0.42 |
| Total Assets | 2.26 | 1.20 |
| Accounts Payable | 0.01 | 0.01 |
| Total Current Liabilities | 0.10 | 0.09 |
| Long-term Debt | 0.00 | 0.00 |
| Total Non-current Liabilities* | 0.06 | 0.06 |
| Total Liabilities | 0.16 | 0.15 |
| Retained Earnings | (0.06) | (1.40) |
| Total Stockholder Equity | 1.81 | (1.39) |
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 50.12 | 39.91 |
| Cost of Revenue | 86.66 | 65.36 |
| Gross Profit | (32.06) | (21.94) |
| Research & Development | 0.24 | 0.06 |
| Selling, General & Admin | 77.73 | 44.12 |
| Total Operating Expenses | 77.98 | 44.17 |
| Operating Income | (110.03) | (66.11) |
| Net Income | (59.09) | (166.22) |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (0.10) | (0.07) |
| Capital Expenditures | 0.06 | 0.04 |
| Free Cash Flow* | (0.16) | (0.11) |
| Investing Cash Flow | (0.07) | (0.17) |
| Financing Cash Flow | 1.09 | -0.00 |
* Derived from reported values
